Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Thalidomide (Thalomid) is a synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 200 mg | $50 | In Stock | |
| 500 mg | $97 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $50 | In Stock | 
| Description | Thalidomide (Thalomid) is a synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  | 
| Targets&IC50 |  CRL4CRBN:250 nM (Kd)  | 
| In vitro | Thalidomide selectively inhibits the production of tumor necrosis factor-alpha (TNF-α) in human monocytes stimulated by lipopolysaccharides and other agonists. Its suppression of TNF-α is mediated through the enhancement of mRNA degradation. Moreover, thalidomide exerts a direct effect on MM cell lines by inducing apoptosis and G1 phase growth arrest, as well as on patient MM cells resistant to melphalan, doxorubicin hydrochloride, and dexamethasone.  | 
| In vivo | Administering 200mg/kg of Thalidomide resulted in the inhibition of vascularization in the corneal region within rabbits, with the inhibition rate ranging from 30% to 51% across three experiments.  | 
| Synonyms | Thalomid, Sedoval | 
| Molecular Weight | 258.23 | 
| Formula | C13H10N2O4 | 
| Cas No. | 50-35-1 | 
| Smiles | O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 | 
| Relative Density. | 1.2944 g/cm3 (Estimated) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 6.5 mg/mL (25.17 mM), Sonication is recommended.   | |||||||||||||||||||||||||
Solution Preparation Table  | ||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.